osimertinib

mitogen-activated protein kinase 3 ; Homo sapiens







3 Article(s)
Download
PMID
Title
Pub. Year
#Total Relationships
1 33511016 AZD9291 Resistance Reversal Activity of a pH-Sensitive Nanocarrier Dual-Loaded with Chloroquine and FGFR1 Inhibitor in NSCLC. 2021 Jan 1
2 34077739 Osimertinib-resistant NSCLC cells activate ERBB2 and YAP/TAZ and are killed by neratinib. 2021 Aug 1
3 31446643 SHR-A1403, a novel c-mesenchymal-epithelial transition factor (c-Met) antibody-drug conjugate, overcomes AZD9291 resistance in non-small cell lung cancer cells overexpressing c-Met. 2019 Nov 2